• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    6.31 Down 0.07(1.10%) Jul 6, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.38
    Open:6.33
    Bid:N/A
    Ask:6.95 x 100
    1y Target Est:19.20
    Beta:-0.12
    Earnings Date:Aug 11 - Aug 18 (Est.)
    Day's Range:6.21 - 6.50
    52wk Range:3.12 - 22.19
    Volume:129,337
    Avg Vol (3m):243,752
    Market Cap:127.48M
    P/E (ttm):N/A
    EPS (ttm):-1.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ADHDDown 1.10%127.48M
    JNJDown 0.24%272.31B
    NVSDown 1.18%238.69B
    SHPGDown 0.52%48.07B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.43
    Quarterly EPS Est (Jun-15) :-0.29
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback